查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1585604

生物相容性材料市场：依材料类型、最终用途划分 - 2025-2030 年全球预测

Biocompatible Materials Market by Material Type (Biocompatible Ceramic, Biocompatible Metals, Natural Polymers), End-use (Academic & Research Institutes, Pharmaceutical) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 186 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年生物相容性材料市场价值为126.3亿美元，预计2024年将达到135.1亿美元，复合年增长率为7.32%，到2030年将达到207.2亿美元。

生物相容性材料是指与活体组织相容且引入体内时不会引起不良反应的物质。对此类材料的需求尤其来自于医疗设备、植入、药物传递系统、组织工程等领域的应用，其中必须将对活生物体的不良反应降至最低。其最终用途主要涵盖医疗保健领域，包括整形外科植入、牙科设备、心血管支架、创伤治疗敷料和隐形眼镜。生物材料市场主要受到人口老化加剧、慢性病盛行率上升以及医疗技术进步推动对创新和有效医疗保健解决方案需求的影响。开发具有更高生物相容性和功能的新型材料存在机会，例如促进组织整合和再生的生物活性陶瓷和聚合物。根据环境永续实践使用生物分解性材料也具有潜力。然而，挑战仍然存在，例如严格的监管要求和高昂的研发成本，这可能会抑制创新并限制新参与企业进入市场。其他限制包括复杂的供应链和原材料品质的变化。对于寻求竞争优势的主要企业来说，投资连接材料科学和生物技术的多方面研究可以带来突破性创新。与学术机构的合作还可以促进尖端生物相容性解决方案的发展。此外，资料主导的市场分析可以为公司提供对新兴趋势和消费者需求的洞察，特别是在个人化医疗和先进伤口护理领域。在技​​术进步和不断变化的医疗保健需求的推动下，市场的本质是高度动态的，需要持续创新和坚实的策略方法来应对挑战并有效利用成长机会。

主要市场统计
基准年[2023] 126.3亿美元
预测年份 [2024] 135.1亿美元
预测年份 [2030] 207.2亿美元
复合年增长率（%） 7.32%

市场动态：快速发展的生物相容性材料市场的关键市场洞察

供需的动态交互作用正在改变生物材料市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时也能帮助企业了解消费行为及其对製造业的影响。

  • 市场驱动因素
    • 先进 3D 生物材料在医疗应用的采用增加。
    • 药物输送系统、美容植入和伤口敷料对生物相容性材料的需求不断增长。
  • 市场限制因素
    • 开发生物相容性材料的高成本
  • 市场机会
    • 越来越关注个人化药物、客製化医疗设备和植入
    • 对再生医学提供支架、组织工程载体和细胞疗法的需求不断增加
  • 市场挑战
    • 生物相容性材料核准的严格法规和标准

波特五力：驾驭生物相容性材料市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解生物相容性材料市场的外部影响

外部宏观环境因素在塑造生物相容材料市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解生物相容材料市场的竞争状况

对生物相容性材料市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵生物相容性材料市场供应商的绩效评估

FPNV定位矩阵是评估生物相容材料市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，以确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议，描绘生物相容性材料市场的成功之路

对于旨在加强在全球市场的影响力的公司来说，生物相容性材料市场的策略分析至关重要。透过考虑关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监管核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 先进 3D 生物材料在医疗应用的采用增加。
      • 药物输送系统、美容植入和伤口敷料对生物相容性材料的需求增加
    • 抑制因素
      • 开发生物相容性材料的高成本
    • 机会
      • 更加关注个人化药物、客製化医疗设备和植入
      • 再生医学需求不断增加：提供支架、组织工程载体和细胞治疗方法
    • 任务
      • 生物相容性材料核准的严格法规和标准
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章依材料类型分類的生物相容性材料市场

  • 生物相容性陶瓷
  • 生物相容性金属
  • 天然聚合物
  • 合成聚合物

第七章生物相容性材料市场：依最终用途

  • 学术研究所
  • 製药

第八章北美和南美生物相容性材料市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第九章亚太地区生物相容材料市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十章欧洲、中东和非洲生物相容材料市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十一章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • 3 H Technology Institute, LLC
  • 3D Systems Corporation
  • Ashland Inc.
  • BASF SE
  • Baxter International, Inc.
  • Celanese Corporation
  • Covestro AG
  • DuPont de Nemours, Inc.
  • Elix Polymers SLU
  • Ensinger GmbH
  • EOS GmbH
  • Evonik Industries AG
  • Formlabs Inc.
  • Foster Corporation.
  • Henkel AG & Co. KGaA,
  • Koninklijke DSM NV
  • Kurt J. Lesker Company GmbH
  • Merck KGaA
  • Mitsubishi Chemical Corporation
  • Renishaw PLC
  • Sandvik AB
  • Shin-Etsu Chemical Co., Ltd.
  • Stratasys Ltd.
  • Stryker Corporation
  • Wacker Chemie AG
Product Code: MRR-521BAA36EA0C

The Biocompatible Materials Market was valued at USD 12.63 billion in 2023, expected to reach USD 13.51 billion in 2024, and is projected to grow at a CAGR of 7.32%, to USD 20.72 billion by 2030.

Biocompatible materials refer to substances that are compatible with living tissue and do not elicit any undesirable reactions when introduced into the body. The necessity for these materials stems from their application in medical devices, implants, drug delivery systems, and tissue engineering, among others, where adverse biological responses must be minimized. Their end-use scope primarily spans healthcare sectors, including orthopedic implants, dental devices, cardiovascular stents, wound healing dressings, and contact lenses. The market for biocompatible materials is primarily influenced by the increasing aging population, the rising prevalence of chronic diseases, and advancements in medical technology that push the demand for innovative and effective healthcare solutions. Opportunities lie in developing novel materials with enhanced biocompatibility and functionality, such as bioactive ceramics and polymers that favor tissue integration and regeneration. There's also potential in leveraging biodegradable materials to align with environmentally sustainable practices. However, challenges persist, notably stringent regulatory requirements and high R&D costs, which can stifle innovation and limit market entry for new entrants. Other constraints include a complex supply chain and variability in raw material quality. For companies aiming to gain a competitive edge, investing in multifaceted research that bridges material science and biotechnology could lead to breakthrough innovations. Partnerships with academic institutions may also facilitate the development of cutting-edge biocompatible solutions. Additionally, leveraging data-driven market analytics can provide companies with insights into emerging trends and consumer needs, particularly in personalized medicine and advanced wound care sectors. The nature of the market is highly dynamic, driven by technological advancements and evolving healthcare demands, necessitating continuous innovation and a robust strategic approach to navigate challenges and capitalize on growth opportunities effectively.

KEY MARKET STATISTICS
Base Year [2023] USD 12.63 billion
Estimated Year [2024] USD 13.51 billion
Forecast Year [2030] USD 20.72 billion
CAGR (%) 7.32%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Biocompatible Materials Market

The Biocompatible Materials Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increase in adoption of advanced 3D biocompatible materials for medical applications.
    • Growing demand for biocompatible materials for drug delivery systems, cosmetic implants, and wound dressing
  • Market Restraints
    • High cost associated with the development of biocompatible materials
  • Market Opportunities
    • Growing focus on personalized medicines and customized medical devices and implants
    • Increasing demand for regenerative medicines for providing scaffolds, carriers for tissue engineering, and cell-based therapies
  • Market Challenges
    • Stringent regulations and standards for approval of biocompatible materials

Porter's Five Forces: A Strategic Tool for Navigating the Biocompatible Materials Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Biocompatible Materials Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Biocompatible Materials Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Biocompatible Materials Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Biocompatible Materials Market

A detailed market share analysis in the Biocompatible Materials Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Biocompatible Materials Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Biocompatible Materials Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Biocompatible Materials Market

A strategic analysis of the Biocompatible Materials Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Biocompatible Materials Market, highlighting leading vendors and their innovative profiles. These include 3 H Technology Institute, LLC, 3D Systems Corporation, Ashland Inc., BASF SE, Baxter International, Inc., Celanese Corporation, Covestro AG, DuPont de Nemours, Inc., Elix Polymers SLU, Ensinger GmbH, EOS GmbH, Evonik Industries AG, Formlabs Inc., Foster Corporation., Henkel AG & Co. KGaA,, Koninklijke DSM N.V., Kurt J. Lesker Company GmbH, Merck KGaA, Mitsubishi Chemical Corporation, Renishaw PLC, Sandvik AB, Shin-Etsu Chemical Co., Ltd., Stratasys Ltd., Stryker Corporation, and Wacker Chemie AG.

Market Segmentation & Coverage

This research report categorizes the Biocompatible Materials Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Material Type, market is studied across Biocompatible Ceramic, Biocompatible Metals, Natural Polymers, and Synthetic Polymers.
  • Based on End-use, market is studied across Academic & Research Institutes and Pharmaceutical.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increase in adoption of advanced 3D biocompatible materials for medical applications.
      • 5.1.1.2. Growing demand for biocompatible materials for drug delivery systems, cosmetic implants, and wound dressing
    • 5.1.2. Restraints
      • 5.1.2.1. High cost associated with the development of biocompatible materials
    • 5.1.3. Opportunities
      • 5.1.3.1. Growing focus on personalized medicines and customized medical devices and implants
      • 5.1.3.2. Increasing demand for regenerative medicines for providing scaffolds, carriers for tissue engineering, and cell-based therapies
    • 5.1.4. Challenges
      • 5.1.4.1. Stringent regulations and standards for approval of biocompatible materials
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Biocompatible Materials Market, by Material Type

  • 6.1. Introduction
  • 6.2. Biocompatible Ceramic
  • 6.3. Biocompatible Metals
  • 6.4. Natural Polymers
  • 6.5. Synthetic Polymers

7. Biocompatible Materials Market, by End-use

  • 7.1. Introduction
  • 7.2. Academic & Research Institutes
  • 7.3. Pharmaceutical

8. Americas Biocompatible Materials Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Biocompatible Materials Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Biocompatible Materials Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. 3 H Technology Institute, LLC
  • 2. 3D Systems Corporation
  • 3. Ashland Inc.
  • 4. BASF SE
  • 5. Baxter International, Inc.
  • 6. Celanese Corporation
  • 7. Covestro AG
  • 8. DuPont de Nemours, Inc.
  • 9. Elix Polymers SLU
  • 10. Ensinger GmbH
  • 11. EOS GmbH
  • 12. Evonik Industries AG
  • 13. Formlabs Inc.
  • 14. Foster Corporation.
  • 15. Henkel AG & Co. KGaA,
  • 16. Koninklijke DSM N.V.
  • 17. Kurt J. Lesker Company GmbH
  • 18. Merck KGaA
  • 19. Mitsubishi Chemical Corporation
  • 20. Renishaw PLC
  • 21. Sandvik AB
  • 22. Shin-Etsu Chemical Co., Ltd.
  • 23. Stratasys Ltd.
  • 24. Stryker Corporation
  • 25. Wacker Chemie AG

LIST OF FIGURES

  • FIGURE 1. BIOCOMPATIBLE MATERIALS MARKET RESEARCH PROCESS
  • FIGURE 2. BIOCOMPATIBLE MATERIALS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL BIOCOMPATIBLE MATERIALS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL BIOCOMPATIBLE MATERIALS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL BIOCOMPATIBLE MATERIALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL BIOCOMPATIBLE MATERIALS MARKET SIZE, BY MATERIAL TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL BIOCOMPATIBLE MATERIALS MARKET SIZE, BY MATERIAL TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL BIOCOMPATIBLE MATERIALS MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL BIOCOMPATIBLE MATERIALS MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS BIOCOMPATIBLE MATERIALS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS BIOCOMPATIBLE MATERIALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES BIOCOMPATIBLE MATERIALS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES BIOCOMPATIBLE MATERIALS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC BIOCOMPATIBLE MATERIALS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC BIOCOMPATIBLE MATERIALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA BIOCOMPATIBLE MATERIALS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA BIOCOMPATIBLE MATERIALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. BIOCOMPATIBLE MATERIALS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. BIOCOMPATIBLE MATERIALS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. BIOCOMPATIBLE MATERIALS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL BIOCOMPATIBLE MATERIALS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL BIOCOMPATIBLE MATERIALS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL BIOCOMPATIBLE MATERIALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. BIOCOMPATIBLE MATERIALS MARKET DYNAMICS
  • TABLE 7. GLOBAL BIOCOMPATIBLE MATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL BIOCOMPATIBLE MATERIALS MARKET SIZE, BY BIOCOMPATIBLE CERAMIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL BIOCOMPATIBLE MATERIALS MARKET SIZE, BY BIOCOMPATIBLE METALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL BIOCOMPATIBLE MATERIALS MARKET SIZE, BY NATURAL POLYMERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL BIOCOMPATIBLE MATERIALS MARKET SIZE, BY SYNTHETIC POLYMERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL BIOCOMPATIBLE MATERIALS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL BIOCOMPATIBLE MATERIALS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL BIOCOMPATIBLE MATERIALS MARKET SIZE, BY PHARMACEUTICAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. AMERICAS BIOCOMPATIBLE MATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 16. AMERICAS BIOCOMPATIBLE MATERIALS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 17. AMERICAS BIOCOMPATIBLE MATERIALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 18. ARGENTINA BIOCOMPATIBLE MATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 19. ARGENTINA BIOCOMPATIBLE MATERIALS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 20. BRAZIL BIOCOMPATIBLE MATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 21. BRAZIL BIOCOMPATIBLE MATERIALS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 22. CANADA BIOCOMPATIBLE MATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 23. CANADA BIOCOMPATIBLE MATERIALS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 24. MEXICO BIOCOMPATIBLE MATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 25. MEXICO BIOCOMPATIBLE MATERIALS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 26. UNITED STATES BIOCOMPATIBLE MATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 27. UNITED STATES BIOCOMPATIBLE MATERIALS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 28. UNITED STATES BIOCOMPATIBLE MATERIALS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 29. ASIA-PACIFIC BIOCOMPATIBLE MATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. ASIA-PACIFIC BIOCOMPATIBLE MATERIALS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 31. ASIA-PACIFIC BIOCOMPATIBLE MATERIALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 32. AUSTRALIA BIOCOMPATIBLE MATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. AUSTRALIA BIOCOMPATIBLE MATERIALS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 34. CHINA BIOCOMPATIBLE MATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. CHINA BIOCOMPATIBLE MATERIALS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 36. INDIA BIOCOMPATIBLE MATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. INDIA BIOCOMPATIBLE MATERIALS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 38. INDONESIA BIOCOMPATIBLE MATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. INDONESIA BIOCOMPATIBLE MATERIALS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 40. JAPAN BIOCOMPATIBLE MATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. JAPAN BIOCOMPATIBLE MATERIALS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 42. MALAYSIA BIOCOMPATIBLE MATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. MALAYSIA BIOCOMPATIBLE MATERIALS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 44. PHILIPPINES BIOCOMPATIBLE MATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. PHILIPPINES BIOCOMPATIBLE MATERIALS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 46. SINGAPORE BIOCOMPATIBLE MATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. SINGAPORE BIOCOMPATIBLE MATERIALS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 48. SOUTH KOREA BIOCOMPATIBLE MATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. SOUTH KOREA BIOCOMPATIBLE MATERIALS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 50. TAIWAN BIOCOMPATIBLE MATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. TAIWAN BIOCOMPATIBLE MATERIALS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 52. THAILAND BIOCOMPATIBLE MATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. THAILAND BIOCOMPATIBLE MATERIALS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 54. VIETNAM BIOCOMPATIBLE MATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. VIETNAM BIOCOMPATIBLE MATERIALS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 56. EUROPE, MIDDLE EAST & AFRICA BIOCOMPATIBLE MATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. EUROPE, MIDDLE EAST & AFRICA BIOCOMPATIBLE MATERIALS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 58. EUROPE, MIDDLE EAST & AFRICA BIOCOMPATIBLE MATERIALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 59. DENMARK BIOCOMPATIBLE MATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. DENMARK BIOCOMPATIBLE MATERIALS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 61. EGYPT BIOCOMPATIBLE MATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. EGYPT BIOCOMPATIBLE MATERIALS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 63. FINLAND BIOCOMPATIBLE MATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. FINLAND BIOCOMPATIBLE MATERIALS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 65. FRANCE BIOCOMPATIBLE MATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. FRANCE BIOCOMPATIBLE MATERIALS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 67. GERMANY BIOCOMPATIBLE MATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. GERMANY BIOCOMPATIBLE MATERIALS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 69. ISRAEL BIOCOMPATIBLE MATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. ISRAEL BIOCOMPATIBLE MATERIALS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 71. ITALY BIOCOMPATIBLE MATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. ITALY BIOCOMPATIBLE MATERIALS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 73. NETHERLANDS BIOCOMPATIBLE MATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. NETHERLANDS BIOCOMPATIBLE MATERIALS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 75. NIGERIA BIOCOMPATIBLE MATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. NIGERIA BIOCOMPATIBLE MATERIALS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 77. NORWAY BIOCOMPATIBLE MATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. NORWAY BIOCOMPATIBLE MATERIALS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 79. POLAND BIOCOMPATIBLE MATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. POLAND BIOCOMPATIBLE MATERIALS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 81. QATAR BIOCOMPATIBLE MATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. QATAR BIOCOMPATIBLE MATERIALS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 83. RUSSIA BIOCOMPATIBLE MATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. RUSSIA BIOCOMPATIBLE MATERIALS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 85. SAUDI ARABIA BIOCOMPATIBLE MATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. SAUDI ARABIA BIOCOMPATIBLE MATERIALS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH AFRICA BIOCOMPATIBLE MATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH AFRICA BIOCOMPATIBLE MATERIALS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 89. SPAIN BIOCOMPATIBLE MATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. SPAIN BIOCOMPATIBLE MATERIALS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 91. SWEDEN BIOCOMPATIBLE MATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. SWEDEN BIOCOMPATIBLE MATERIALS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 93. SWITZERLAND BIOCOMPATIBLE MATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. SWITZERLAND BIOCOMPATIBLE MATERIALS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 95. TURKEY BIOCOMPATIBLE MATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. TURKEY BIOCOMPATIBLE MATERIALS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 97. UNITED ARAB EMIRATES BIOCOMPATIBLE MATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED ARAB EMIRATES BIOCOMPATIBLE MATERIALS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED KINGDOM BIOCOMPATIBLE MATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. UNITED KINGDOM BIOCOMPATIBLE MATERIALS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 101. BIOCOMPATIBLE MATERIALS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 102. BIOCOMPATIBLE MATERIALS MARKET, FPNV POSITIONING MATRIX, 2023